The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...
Boston-area startup Mediar Therapeutics is teaming up with Eli Lilly on a new drug for idiopathic pulmonary fibrosis. Lilly — one of the five large pharmas backing Mediar – will pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback